Serum osteoprotegerin and receptor activator of nuclear factor-κB ligand (RANKL) concentrations in allogeneic stem cell transplant-recipients: a role in bone loss?

Author： Kananen K.   Volin L.   Laitinen K.   Ruutu T.   Välimäki M.  

Publisher： Springer Publishing Company

ISSN： 0937-941X

Source： Osteoporosis International, Vol.17, Iss.5, 2006-05, pp. : 724-730

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: Are they of any help?

By Wagner Doris  

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 17-18, 2010-09 ,pp. : 452-457

Springer Publishing Company

Access to resources Recommend Favorite

Implications of Measuring Soluble Receptor Activators of Nuclear Factor-κB Ligand and Osteoprotegerin in Bone Metabolism of Elderly Women

By  

Gerontology, Vol. 55, Iss. 3, 2009-01 ,pp. : 275-280

Karger

Access to resources Recommend Favorite

Preoperative Serum Receptor Activator of Nuclear Factor-κB Ligand/Osteoprotegerin Predict Stabilization of Spontaneously Restored Sinus Rhythm in Persistent Atrial Fibrillation Patients after Mitral Valve Surgery

By  

Cardiology, Vol. 127, Iss. 3, 2014-01 ,pp. : 183-189

Karger

Access to resources Recommend Favorite

Increased Calcification in Osteoprotegerin-Deficient Smooth Muscle Cells: Dependence on Receptor Activator of NF-κB Ligand and Interleukin 6

By  

Journal of Vascular Research, Vol. 51, Iss. 2, 2014-03 ,pp. : 118-131

Karger

Access to resources Recommend Favorite

The receptor activator of NF‐κB ligand‐osteoprotegerin system in pulpal and periapical disease

By  

INTERNATIONAL ENDODONTIC JOURNAL, Vol. 46, Iss. 2, 2013-02 ,pp. : 99-111

John Wiley & Sons Inc

Access to resources Recommend Favorite